title: Management of isolated demyelinating episodes by North American neurologists.
authors.forename: Alex
authors.initials: A
authors.lastname: Tselis
authors.forename: Seemant
authors.initials: S
authors.lastname: Chaturvedi
authors.forename: Mark
authors.initials: M
authors.lastname: Borsody
authors.forename: Rohan
authors.initials: R
authors.lastname: Vaidya
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002170:Canada; D003711:Demyelinating Diseases / Q000175:diagnosis / Q000188:drug therapy*; D004568:Electrodiagnosis / Q000706:statistics & numerical data; D019538:Health Care Surveys; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy; D009462:Neurology / Q000379:methods* / Q000592:standards; D015835:Ocular Motility Disorders / Q000175:diagnosis / Q000188:drug therapy; D009902:Optic Neuritis / Q000175:diagnosis / Q000188:drug therapy; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D013129:Spinal Puncture / Q000706:statistics & numerical data; D011795:Surveys and Questionnaires; D014481:United States